Amgen (AMGN) Goodwill & Intangibles (2009 - 2026)

Amgen (AMGN) recorded quarterly Goodwill & Intangibles of $40.1 billion in Q1 2026, down 2.2% quarter-over-quarter from $41.0 billion in Q4 2025, and up 70.84% on a YoY basis from $23.4 billion in Q1 2025.

Amgen (AMGN) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Amgen's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $40.1 billion for Q1 2026.

  • In Q1 2026, Goodwill & Intangibles rose 70.84% year-over-year to $40.1 billion; the TTM figure through Mar 2026 stood at $40.1 billion (up 70.84% YoY), while the FY2025 annual figure was $41.0 billion, down 11.61% from the prior year.
  • Goodwill & Intangibles was $40.1 billion for Q1 2026 at Amgen, down from $41.0 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $51.3 billion in Q4 2023 to a low of $19.0 billion in Q2 2025.
  • Historically, Goodwill & Intangibles has averaged $36.3 billion across 5 years, with a median of $31.6 billion in 2022.
  • The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles sank 61.01% in 2025, then jumped 70.84% in 2026.
  • A 5-year view of Goodwill & Intangibles shows it stood at $31.6 billion in 2022, then soared by 62.2% to $51.3 billion in 2023, then retreated by 9.62% to $46.3 billion in 2024, then retreated by 11.61% to $41.0 billion in 2025, then decreased by 2.2% to $40.1 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $40.1 billion (Q1 2026), $41.0 billion (Q4 2025), and $41.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 40.05 Bn
Dec 31, 2025 40.96 Bn
Sep 30, 2025 41.82 Bn
Jun 30, 2025 19.02 Bn
Mar 31, 2025 23.45 Bn
Dec 31, 2024 46.34 Bn
Sep 30, 2024 47.58 Bn
Jun 30, 2024 48.79 Bn
Mar 31, 2024 49.94 Bn
Dec 31, 2023 51.27 Bn
Sep 30, 2023 28.66 Bn
Jun 30, 2023 30.16 Bn
Mar 31, 2023 30.92 Bn
Dec 31, 2022 31.61 Bn
Sep 30, 2022 28.11 Bn
Jun 30, 2022 28.79 Bn
Mar 31, 2022 29.46 Bn
Dec 31, 2021 30.07 Bn
Sep 30, 2021 29.32 Bn
Jun 30, 2021 29.98 Bn